NORTH AMERICA, EUROPE, AND AUSTRALIA PEANUT ALLERGY TREATMENT MARKET ANALYSIS

North America, Europe, and Australia Peanut Allergy Treatment Market, by Drug Type (Epinephrine, Antihistamine, (Loratadine, Diphenhydramine, Others), Palforzia, Pipeline Drugs(Viaskin Peanut, Ligelizumab, CA002, PRT120, Dupilumab), by Route of Administration (Oral, Parenteral, Intranasal and Epicutaneous), by Distribution Channel, (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, and Australia) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jun 2022
Code : CMI5041
Pages :370
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key Players

Key players operating in market the market include DBV Technologies, Aimmune Therapeutics, Inc., Prota Therapeutics Pty Ltd., COUR Pharmaceuticals, BlueWillow Biologics, HAL Allergy B.V., Allergy Therapeutics PLC., Novartis AG, Regeneron Pharmaceuticals, Inc., Vedanta Biosciences, Inc., Cambridge Allergy Ltd. (Camallergy), Angany Inc., Moonlight Therapeutics Inc., Allero Therapeutics B.V., Sanofi, Johnson & Johnson, Viatris Inc. (Mylan N.V.), Sun Pharmaceutical Industries Ltd., Bayer AG, Aurobindo Pharma Limited., Astellas Pharma Inc., Siolta Therapeutics, DESENTUM OY, ALK, Immunomic Therapeutics, Inc., Stallergenes Greer Ltd.

North America, Europe, and Australia Peanut Allergy Treatment Market Report Snapshots